Delivery Order SPE2DB22D3301-SPE2DB24FX6DE
Award Date
11/29/23
Potential Completion Date
12/20/23
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product, with a ceiling value of $19,875.72 and a performance period through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,371.90, is for the procurement of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 12, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,875.72, is for the supply of the pharmaceutical product OPDIVO 240 MG/24 ML VIAL 24ML. The contract has an ultimate completion date of February 25, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,128.84, is for the supply of OPDIVO 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,689.30, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract is a firm fixed-price delivery order, with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract is a Firm Fixed Price delivery order with a ceiling value of $30,589.60 and a period of performance through August 28, 2024. This contract award is not associated with a set-aside designation. As a key supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract has a total ceiling value of $7,647.40 and an ultimate completion date of October 7, 2024. It is a firm fixed-price contract and does not have any set-aside designations. Amerisourcebergen, through its Corporate Office division, will be responsible for delivering these pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,813.58 firm fixed-price contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product, with a completion date of February 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of pharmaceutical products, including the drug Opdivo, with a ceiling value of $15,294.80. The contract has an ultimate completion date of November 4, 2024 and is a firm fixed-price delivery order. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product, with a ceiling value of $19,875.72 and a period of performance through March 13, 2025. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen holds a larger Indefinite...